Founded and led by Dr. Nancy Hedlund (PhD, MBA, RPh), MedNavigate combines deep scientific rigor with strategic advisory services to help early- and mid-cap life sciences companies chart the path from product discovery through commercialization. The consultancy specializes in designing and executing RWE strategies supporting literature reviews, evidence roadmapping, study protocol development, and value communication for regulatory and payer submissions. In a landscape increasingly shaped by value-based and evidence-driven criteria, MedNavigate acts as a beacon, aligning technical evidence generation with business outcomes. Dr. Hedlund draws upon her extensive experience from institutional clinical practice to leading consulting engagements with organizations like Baxter, Astellas, and PTC Therapeutics to offer data-driven and patient-centric guidance across pharmaceutical, device, and diagnostic domains.